Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 March 2025 - 10:32

Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-13-1170

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters